Akums Drugs & Pharmaceuticals IPO

Akums Drugs and Pharmaceuticals is a contract development and manufacturing organisation (CDMO). The company primarily provides product development and manufacturing solutions to its clients. This includes services such as formulation research and development (R&D), regulatory dossier preparation and filing in both Indian and international markets, and various testing services. In addition to its primary CDMO operations, Akums Drugs and Pharmaceuticals markets its own branded formulations both in India and internationally. The company does this through its subsidiaries, Akumentis and Unosource. Akumentis is involved in therapy areas such as gynaecology, cardiology, orthopaedics, and paediatrics, while Unosource is engaged in anti-infectives, analgesics, the central nervous system, and gynaecology. The company has a presence in 65 countries. International clients include Allegens in Vietnam, Ambica International in the Philippines, Caferma SAC in Peru, JDS and Pharma Apex in Myanmar, Master Pharma in Cambodia, Olainfarm in Latvia, Planet Pharmaceutical in Tanzania, and Unisel in Kenya, among others. The company also engages in the marketing of trade generic and private label products across India through various distributors and alternative channels.;